TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Icecure Medical ( (ICCM) ) is now available.
On November 19, 2025, IceCure Medical reported its financial and operational results for the nine months ending September 30, 2025. A significant development was the FDA’s marketing authorization in October 2025 for the ProSense® cryoablation system, targeting low-risk breast cancer in women aged 70 and above. This milestone is expected to drive demand and commercial momentum in the U.S. and globally. The company anticipates an increase in ProSense® installations and procedure volumes, with regulatory approvals expanding in markets like Switzerland. Despite a slight revenue decline, IceCure is optimistic about future growth, supported by new clinical studies and regulatory milestones.
The most recent analyst rating on (ICCM) stock is a Sell with a $1.00 price target. To see the full list of analyst forecasts on Icecure Medical stock, see the ICCM Stock Forecast page.
Spark’s Take on ICCM Stock
According to Spark, TipRanks’ AI Analyst, ICCM is a Underperform.
Icecure Medical’s overall stock score is primarily impacted by its significant financial challenges, including declining revenues and substantial losses. Technical indicators also show weak momentum, further contributing to a low score. While there is potential regulatory progress with ProSense, financial difficulties and poor valuation metrics weigh heavily on the stock’s outlook.
To see Spark’s full report on ICCM stock, click here.
More about Icecure Medical
IceCure Medical Ltd. is a developer of minimally-invasive cryoablation technology that destroys tumors by freezing, offering an alternative to surgical tumor removal. The company focuses on the treatment of breast cancer and other indications, with a significant market presence in the U.S. and internationally.
Average Trading Volume: 1,626,483
Technical Sentiment Signal: Sell
Current Market Cap: $48.68M
For a thorough assessment of ICCM stock, go to TipRanks’ Stock Analysis page.